Designed a customizable suite of dashboards and reports with robust data analytics and industry benchmarks to generate a 6-month pay back time on solution, 75% reduction in ad-hoc report TAT for employers, and $4K Rx savings per script for HIV patients.
West coast in-home care payvider ❯
Comprehensive support for your top value-based care priorities
MedeAnalytics helps payers gain self-service visibility into drivers of cost and quality, allowing them to transform their relationship with clients and impact on population health management. With the ability to track, trend and drill down into root causes, payers can understand where there are opportunities to combat some of today’s biggest challenges. These include:
- Management of value-based care programs
- High treatment costs
- Ineffective identification of at-risk members
- Unnecessary hospital utilization
- Provider negotiations
- Lack of transparency with employers
- Population health and quality management
![[Wheel graphic displaying the following] Member care: - Care Quality - Care Utilization - Employer Relations - Provider Contracting - At-Risk Populations - Cost of Care](https://medeanalytics.com/wp-content/uploads/2022/12/Payer-Analytics-Wheel.png "Payer Analytics Wheel")
Go further: Explore our Payer Value Analytics solutions
Talk with our experts about the power of analytics
Get our take on industry trends
MedeAnalytics at HIMSS26: Turning Insight into Measurable Healthcare Performance
March 9-12, 2026 | Venetian Convention & Expo Center | Las Vegas As margin pressure intensifies and value-based care…
Read on...
Turning social risk into measurable financial performance
Payers increasingly recognize that social risk factors materially influence total cost of care, utilization, and quality performance. Yet for many…
Read on...
The GLP-1 Insights Series, Part 2: Maximizing impact and savings through analytics
GLP-1s present a major opportunity for organizations to improve clinical outcomes and reduce long-term healthcare costs. However, payers and providers…
Read on...
The GLP-1 Insights Series, Part 1: Long-term impact on costs and outcomes for payers and providers
Few pharmaceuticals have surged in popularity as fast as GLP-1s. This growth is well-justified. GLP-1s, a class of medications originally…
Read on...